Teva Pharmaceutical Industries reported $13.53B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Aspen Pharmacare ZAR 15.77B 1.73B Dec/2025
Cipla INR 70.14B 7.16B Mar/2026
Dr.Reddys Laboratories INR 167.47B 9.16B Mar/2026
Guangzhou Baiy CNY 40.76B 1.64B Mar/2026
Jiangsu Hengrui CNY 5.64B 732.51M Mar/2026
Kalbe Farma IDR 4.67T 26.76B Sep/2025
Richter Gedeon HUF 179.31B 8.13B Mar/2026
Sh Fosun Pharma CNY 36.58B 156.4M Mar/2026
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026